Madhavan Balachandran
EVP, Operations, Amgen.
Companies
- Stevanato GroupBoard member Mar 18, 2026 to now1
- Replimune Group, Inc.Board member Sep 5, 2024 to now2
- uniQure N.V.Board member Sep 22, 2017 to now3
- Catalent Pharma SolutionsBoard member May 8, 2017 to Oct 31, 20234
- AmgenEVP, Operations Aug 15, 2012 to May 5, 20165
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
Stevanato Group STVN69,458 shares6$1.3M at $18.91Jun 15, 2026- uniQure N.V. QURE43,254 shares7$967.6K at $22.37Jun 17, 2026
Catalent Pharma Solutions CTLT27,441 shares8Oct 27, 2023
As of each latest filing. The line shows shares held over time.
Recent filings
- Jun 17, 2026Sold 1,690 shares at $42.60 of uniQure N.V.7
- Jun 17, 2026Sold 4,700 shares at $43.66 of uniQure N.V.7
- Jun 17, 2026Sold 5,295 shares at $47.08 of uniQure N.V.7
- Jun 17, 2026Exercised options 6,390 shares at $19.39 of uniQure N.V.7
- Jun 17, 2026Exercised options 5,295 shares at $31.71 of uniQure N.V.7
- Jun 15, 2026Sold 10,000 shares at $27.85 of uniQure N.V.9
- Jun 15, 2026Sold 1,493 shares at $17.09 of Stevanato Group6
- Jun 15, 2026Exercised options 10,000 shares at $8.49 of uniQure N.V.9
- Jun 12, 2026Granted 4,975 shares of Stevanato Group6
- Jun 11, 2026Sold 1,993 shares at $27.06 of uniQure N.V.10
- Jun 10, 2026Granted 7,550 shares of uniQure N.V.10
- Jun 20, 2025Sold 2,112 shares at $14.45 of uniQure N.V.11
- Jun 11, 2025Granted 7,970 shares of uniQure N.V.12
- Jun 19, 2024Granted 8,080 shares of uniQure N.V.13
- Jun 13, 2024Sold 2,231 shares at $5.12 of uniQure N.V.14
- Oct 27, 2023Granted 6,993 shares of Catalent Pharma Solutions8
- Jun 16, 2023Sold 2,283 shares at $18.91 of uniQure N.V.15
- Jun 13, 2023Granted 8,700 shares of uniQure N.V.15
- Feb 27, 2023Sold 384 shares at $19.99 of uniQure N.V.16
- Oct 27, 2022Granted 4,149 shares of Catalent Pharma Solutions17
- Jun 15, 2022Granted 9,080 shares of uniQure N.V.18
- Feb 28, 2022Sold 602 shares at $16.70 of uniQure N.V.19
- Feb 24, 2022Granted 1,534 shares of uniQure N.V.20
- Oct 28, 2021Granted 1,402 shares of Catalent Pharma Solutions21
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1SEC EDGARStevanato Group, Board member
- 2SEC EDGARReplimune Group, Inc., Board member
- 3SEC EDGARuniQure N.V., Board member
- 4
- 5SEC EDGARAmgen, EVP, Operations
- 6
- 7
- 8
- 9SEC EDGARForm 4 filed Jun 17, 2026
- 10SEC EDGARForm 4 filed Jun 12, 2026
- 11SEC EDGARForm 4 filed Jun 24, 2025
- 12SEC EDGARForm 4 filed Jun 13, 2025
- 13SEC EDGARForm 4 filed Jun 21, 2024
- 14SEC EDGARForm 4 filed Jun 17, 2024
- 15SEC EDGARForm 4 filed Jun 20, 2023
- 16SEC EDGARForm 4 filed Mar 1, 2023
- 17SEC EDGARForm 4 filed Oct 31, 2022
- 18SEC EDGARForm 4 filed Jun 17, 2022
- 19SEC EDGARForm 4 filed Mar 2, 2022
- 20SEC EDGARForm 4 filed Feb 28, 2022
- 21SEC EDGARForm 4 filed Nov 1, 2021